Gene mutations in the Ras pathway and the prognostic implication in Korean patients with juvenile myelomonocytic leukemia

Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia

(2010) Benoîte Pérez et al.   BRITISH JOURNAL OF HAEMATOLOGY

Molecular basis of juvenile myelomonocytic leukemia

(2010) A. C.H. de Vries et al.   HAEMATOLOGICA

Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia

(2010) Charlotte M Niemeyer et al.   NATURE GENETICS

Mutations in CBL occur frequently in juvenile myelomonocytic leukemia

(2009) M. L. Loh et al.   BLOOD

Correlation of Clinical Features With the Mutational Status of GM-CSF Signaling Pathway-Related Genes in Juvenile Myelomonocytic Leukemia

(2009) Nao Yoshida et al.   PEDIATRIC RESEARCH

Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia

(2008) Kenichi Koike et al.   BRITISH JOURNAL OF HAEMATOLOGY

The tyrosine phosphatase Shp2 (PTPN11) in cancer

(2008) Gordon Chan et al.   CANCER AND METASTASIS REVIEWS

Activating PTPN11 mutants promote hematopoietic progenitor cell-cycle progression and survival

(2008) Zhenyun Yang et al.   EXPERIMENTAL HEMATOLOGY

Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia

(2008) P D Emanuel   LEUKEMIA

Juvenile myelomonocytic leukemia: A report from the 2nd International JMML Symposium

(2008) Rebecca J. Chan et al.   LEUKEMIA RESEARCH

Juvenile myelomonocytic leukemia with less aggressive clinical course and KRAS mutation

(2008) Masaru Imamura et al.   PEDIATRIC BLOOD & CANCER